Arch Biopartners 주식 가격. ARCH - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

가격

2.01

매수가

2.01

매도가

2.02

거래량

5,000

2.01 일간 변동폭 2.03

1.09 52주 범위 2.56

market_cap

125.822M

전일 종가

2.01

개장가

2.02

최근 거래 시간

300

2.01

마지막 거래 시간

재정 규모

VWAP

평균 볼륨(3m)

14,300

발행 주식

62,598,000

배당수익률

주가수익률

-37.85

주당순이익(EPS)

-0.05

매출

1.98M

순이익

-3.33M

섹터

Coml Physical, Biologcl Resh

산업

Advertising Agencies

웹사이트

archbiopartners.com

본부

Toronto, Ontario, Can

설립됨

2010

Arch Biopartners Inc is listed in the Coml Physical, Biologcl Resh sector of the TSX 벤처 거래소 with ticker ARCH. The last closing price for Arch Biopartners was $2.01. Over the last year, Arch Biopartners shares have traded in a share price range of $ 1.09 to $ 2.56.

Arch Biopartners currently has 62,598,000 shares in issue. The market capitalisation of Arch Biopartners is $125.82 million. Arch Biopartners has a price to earnings ratio (PE ratio) of -37.85.

Arch Biopartners Announces Dosing of First Patient in Canada in the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury

TORONTO, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that patient recruitment and dosing have begun...

Arch Biopartners Arranges Non-Brokered Private Placement

TORONTO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has arranged a non-brokered private placement...

Closes Units for Debt Settlement

TORONTO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the Company has closed a transaction that...

Units for Debt Settlement

TORONTO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the Company has arranged a transaction to...

Arch Biopartners Announces Alberta Health Services Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury (CS-AKI)

TORONTO, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that Alberta Health Services (AHS) has approved...

Arch Biopartners’ Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting Acute Kidney Injury Caused by Drug Toxins

Arch is repurposing cilastatin, a dipeptidase-1 inhibitor, as a new treatment for acute kidney injury (AKI)Cilastatin is particularly well suited to prevent AKI caused by drug toxins due to its...

Arch Biopartners Closes Non-Brokered Private Placement

TORONTO, July 30, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has closed the non-brokered private placement...

Arch Biopartners Arranges Non-Brokered Private Placement

TORONTO, July 29, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has arranged a non-brokered private placement...

Arch Biopartners Announces GMP Manufacturing of Cilastatin Drug Product

TORONTO, June 27, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced that Dalton Pharma Services (Dalton) has completed the...

Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI)

TORONTO, June 18, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that the University of Calgary’s Conjoint Health...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	-0.03	-1.47058823529	2.04	2.1	1.9	14931	1.98871901	CS
4	-0.13	-6.07476635514	2.14	2.14	1.84	21005	1.99972978	CS
12	0.53	35.8108108108	1.48	2.2	1.36	14300	1.85796622	CS
26	0.3	17.5438596491	1.71	2.2	1.36	15881	1.71616451	CS
52	0.88	77.8761061947	1.13	2.56	1.09	20486	1.77281192	CS
156	-2.17	-51.9138755981	4.18	5.3	0.97	21586	2.43259736	CS
260	1.04	107.216494845	0.97	5.3	0.74	27076	1.98008883	CS

가장 활성
% 상승자
% 패자

기호	가격	볼륨
WAV.HPepcap Resources Inc	$ 0.04 (300.00%)	10k
FONC.PFlorence One Capital Inc	$ 0.07 (180.00%)	25k
MAHMarksmen Energy Inc	$ 0.01 (100.00%)	13.83k
ENTGEntourage Health Corp	$ 0.01 (100.00%)	41.13k
ALTAlturas Minerals Corp	$ 0.01 (100.00%)	1,000
CSTL.PCastlecap Capital Inc	$ 0.025 (-58.33%)	5k
SOP.HSoperior Fertilizer Corp	$ 0.005 (-50.00%)	12k
CPLCopper Lake Resources Ltd	$ 0.005 (-50.00%)	2.04k
ICRSIcarus Capital Corp	$ 0.015 (-40.00%)	1,000
OKAIEvokai Creative Labs Inc	$ 0.02 (-33.33%)	150k
BARUBaru Gold Corp	$ 0.025 (25.00%)	3.47M
DMDataMetrex AI Limited	$ 0.005 (0.00%)	1.71M
FUUF3 Uranium Corp	$ 0.23 (4.55%)	1.71M
GXUGoviEx Uranium Inc	$ 0.07 (7.69%)	1.66M
AECAnfield Energy Inc	$ 0.115 (0.00%)	1.61M